Loperamide—an Opiate Receptor Agonist with Gastrointestinal Motility Effects
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 22 (sup130) , 65-66
- https://doi.org/10.3109/00365528709091001
Abstract
Loperamide is an opiate agonist, also exerting activity by inhibiting the action of calmodulin. The mode of action in the clinic is probably mainly due to its action on opiate receptors, since the effects of loperamide can be reversed by naloxone. The exclusive, action in the gut is explained by the specific distribution of loperamide with extensive distribution to the gut and minimal influence on opiate receptors in CNS. Loperamide is well absorbed after oral administration and extensively metabolized. The pharmacokinetic properties are linear over a wide dose range.Keywords
This publication has 10 references indexed in Scilit:
- Editorial commentCurrent Therapeutic Research, 2002
- Loperamide has antisecretory activity in the human jejunum in vivo.Gut, 1984
- Relationship between anti-diarrheal activity and binding to calmodulinEuropean Journal of Pharmacology, 1982
- Loperamide: studies on its mechanism of action.Gut, 1981
- Pharmacology and antidiarrheal effect of loperamideDrug Development Research, 1981
- Distribution of loperamide in the intestinal wallBiochemical Pharmacology, 1979
- Human Pharmacokinetics and Comparative Bioavailability of Loperamide HydrochlorideThe Journal of Clinical Pharmacology, 1979
- LoperamideDrugs, 1978
- Receptor affinity and pharmacological potency of a series of narcotic analgesic, anti-diarrheal and neuroleptic drugsEuropean Journal of Pharmacology, 1977
- Radioimmunoassay of the antidiarrhoeal loperamideLife Sciences, 1977